Originally published on the Greenphire website prior to the merger with Suvoda in 2025.
Greenphire works with a global biotechnology company on a mission to develop precision medicine for rare diseases. Rare diseases, by nature, impact fewer people globally than other therapeutic areas resulting in rare disease patients having to travel greater distances to participate in a clinical trial. As such, this sponsor selected Greenphire’s ConneX global travel service to manage their trial logistics and ease the burden for clinical trial participants.